Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

Chronic hepatitis B infection (CHB) is a significant problem worldwide with around 300 million people infected. Ambitious goals have been set towards its elimination as a public health threat by 2030. However, accurate seroprevalence estimates in many countries are lacking or fail to provide represe...

Full description

Bibliographic Details
Main Authors: Louise O. Downs, Cori Campbell, Michael Abouyannis, Mark Otiende, Melissa Kapulu, Christina W. Obiero, Mainga Hamaluba, Caroline Ngetsa, Monique I. Andersson, George Githinji, George Warimwe, Kathy Baisley, J. Anthony G. Scott, Philippa C. Matthews, Anthony Etyang
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Virus Eradication
Subjects:
Chronic hepatitis B
Clinical trials
Seroprevalence
Elimination goals
Clinical care
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664023000419

Internet

http://www.sciencedirect.com/science/article/pii/S2055664023000419

Similar Items